Sercloremine

Sercloremine
	IUPAC name 4-(5-Chloro-1-benzofuran-2-yl)-1-methylpiperidine
Identifiers
CAS number	54403-19-9
PubChem	162748
ChemSpider	142883
Jmol-3D images	Image 1
	SMILES Cl.Clc3cc1c(oc(c1)C2CCN(C)CC2)cc3 ;
	InChI InChI=InChI=1S/C14H16ClNO.ClH/c1-16-6-4-10(5-7-16)14-9-11-8-12(15)2-3-13(11)17-14;/h2-3,8-10H,4-7H2,1H3;1H ;
Properties
Molecular formula	C14H16ClNO
Molar mass	249.74 g mol−1
	Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
	Infobox references

Sercloremine, usually as a hydrochloride, is an experimental drug candidate under study as an antidepressant.^[2] This drug was developed by Novartis and is in Phase II clinical trials.^[3]

[edit] References

^ "Chemical data". guidechem. Retrieved July 29, 2011.
^ US Patent 4600719 - Tetrahydropyridine and piperidine derivatives
^ "Chemdrug data page" (in Chinese, and English). Chemdrug. Retrieved July 29, 2011.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.